Facioscapulohumeral muscular dystrophy: Do neurotrophins play a role?

Muscle and Nerve

Volumn 41, Issue 1, 2010, Pages 120-127

  Angelucci, Francesco ^a,b   Colantoni, Luca ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UILDM   (Italy)

Author keywords

FSHD; Muscle development; Muscle regeneration; Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTEROID; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; SALBUTAMOL;

BRAIN REGION; CELL DIFFERENTIATION; CELL INTERACTION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; EXERCISE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE LOCATION; GENE OVEREXPRESSION; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; MOTONEURON; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NERVE CELL PLASTICITY; NERVE FUNCTION; NERVE GROWTH; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NERVE GROWTH FACTORS;

EID: 73949113478     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21505     Document Type: Review

References (93)

1. Van der Maarel SM, Frants RR, Padberg GW. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta 2007; 1772:186-194.
2. Tawil R. Facioscapulohumeral muscular dystrophy. Neuro-therapeutics. 2008;5:601-606.
3. Pandya S, King WM, Tawil R. Facioscapulohumeral dystrophy. Phys Ther 2008;88:105-113.
4. Wohlgemuth M, van der Kooi EL, van Kesteren RG, van der Maarel SM, Padberg GW. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 2004;63:176-178.
5. Lyle R, Wright TJ, Clark LN, Hewitt JE. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeoboxcontaining repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics 1995;28:389-397.
6. Gabriëls J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999;236: 25-32.
7. Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994;3:1287-1295.
8. Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, et al. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007;81:264-279.
9. Rijkers T, Deidda G, van Koningsbruggen S, van Geel M, Lemmers RJ, van Deutekom JC, et al. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet 2004;41:826-836.
10. Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002;110:339-348.
11. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003;12:2909-2921.
12. Hanel ML, Wuebbles RD, Jones PL. Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev Dyn 2009;238:1502-1512.
13. Van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003;34:315-317.
14. Hallbook F. Evolution of the vertebrate neurotrophin and Trk receptor gene families. Curr Opin Neurobiol 1999;9: 616-621.
15. Götz R, Köster R, Winkler C, Raulf F, Lottspeich F, Schartl M, et al. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 1994;372:266.
16. Lai KO, Fu WY, Ip FCF, Ip NY. Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol Cell Neurosci 1998;11:64.
17. Ibanez CF. Emerging themes in structural biology of neuro-trophic factors. Trends Neurosci 1998;21:438-444.
18. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-1162.
19. Korsching S. The neurotrophic factor concept: a reexamination. J Neurosci 1993;13:2739-2748.
20. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 1985;74:1389-1393.
21. Rocamora N, Pascual M, Acsady L, de Lecea L, Freund TF, Soriano E. Expression of NGF and NT3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J Neurosci 1996;16:3991-4004.
22. Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994;263:1618-1623.
23. Lindholm D, Carroll P, Tzimagiogis G, Thoenen H. Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4. Eur J Neurosci 1996;8:1452-1460.
24. Alderson RF, Alterman AL, Barde YA, Lindsay RM. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990;5:297-306.
25. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991;350: 230-232.
26. Altar CA, Di Stefano PS. Neurotrophin trafficking by anterograde transport. Trends Neurosci 1998;21:433-437.
27. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A 2002;87:5454-5458.
28. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/brain derived neurotrophic factor family. Nature 1990; 344:339-341.
29. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990;247: 1446-1451.
30. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994;369:658-661.
31. Tessarollo L, Vogel K, Palko M, Reid S, Parada L. Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons. Proc Natl Acad Sci U S A 1994;91: 11844-11848.
32. Klein R, Silos-Santiago I, Smeyne R, Lira S, Brambilla R, Bryant S, et al. Disruption of the neurotrophin-3 receptor gene trkC eliminates 1a muscle afferents and results in abnormal movements. Nature 1994;368:249-251.
33. Gall CM, Gold SJ, Isackson PJ, Seroogy KB. Brain derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 1992;3:56-63.
34. Friedman WJ, Ibanez CF, Hallbook F, Persson H, Cain LD, Dreyfus CF, et al. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol 1993; 119:72-78.
35. Yin Q, Kemp GJ, Yu LG, Wagstaff SC, Frostick SP. Neurotrophin-4 delivered by fibrin glue promotes peripheral nerve regeneration. Muscle Nerve 2001;24:345-351.
36. Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci U S A 1992;89:3060-3064.
37. Gotz R, Schartl M. The conservation of neurotrophic factors during vertebrate evolution. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1994;108:1-10.
38. Taylor S, Srinivasan B, Wordinger RJ, Roque RS. Glutamate stimulates neurotrophin expression in cultured Muller cells. Brain Res Mol Brain Res 2003;111:189-197.
39. Yin Q, Kemp GJ, Yu LG, Wagstaff SC, Frostick SP. Expression of Schwann cell-specific proteins and low-molecularweight neurofilament protein during regeneration of sciatic nerve treated with neurotrophin-4. Neuroscience 2001;105: 779-783.
40. Schwyzer L, Mateos JM, Abegg M, Rietschin L, Heeb L, Thompson SM, et al. Physiological and morphological plasticity induced by chronic treatment with NT-3 or NT-4/5 in hippocampal slice cultures. Eur J Neurosci 2002;16: 1939-1948.
41. Barbacid M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann N Y Acad Sci 1995;766:442-458.
42. Bothwell M,. p75NTR: a receptor after all. Science 1999; 272:506-507.
43. Chao MV, Hempstead BL. p75 and Trk: a two-receptor system. Trends Neurosci 1995;18:321-326.
44. Dechant G. Molecular interactions between neurotrophin receptors. Cell Tissue Res 2001;305:229-238.
45. Kaplan DR, Miller FD. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 1997;9:213-221.
46. Klein R. Role of neurotrophins in mouse neuronal development. FASEB J 1994;8:738-744.
47. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, et al. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002; 36:375-386.
48. Harrington AW, Leiner B, Blechschmitt C, Arevalo JC, Lee R, Mörl K, et al. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc Natl Acad Sci U S A 2004;101:6226.
49. Saka Y, Yoshimura O, Tahara H, Takeda Y, Moriyama H, Maejima H, et al. The mRNA expression of neurotrophins in different skeletal muscles of young rats. Hiroshima J Med Sci 2007;56:23-28.
50. Seidl K, Erck C, Buchberger A. Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J Cell Physiol 1998;176:10-21.
51. Rende M, Brizi E, Conner J, Treves S, Censier K, Provenzano C, et al. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci 2000;18:869-885.
52. Zhan WZ, Mantilla CB, Sieck GC. Regulation of neuromuscular transmission by neurotrophins. Sheng Li Xue Bao 2003;55:617-624.
53. Mantilla CB, Zhan WZ, Sieck GC. Neurotrophins improve neuromuscular transmission in the adult rat diaphragm. Muscle Nerve 2004;29:381-386.
54. Mousavi K, Jasmin BJ. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci 2006;26:5739-5749.
55. Lohof AM, Ip NY, Poo MM. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993;363:350-353.
56. Wang, T, Xie K, Lu B. Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci 1995;15: 4796-4805.
57. Fu AK, Ip FC, Lai KO, Tsim KW, Ip NY. Muscle-derived neurotrophin-3 increases the aggregation of acetylcholine receptors in neuron-muscle co-cultures. Neuroreport 1997; 8:3895-3900.
58. Xie K, Wang T, Olafsson P, Mizuno K, Lu B. Activity dependent expression of NT-3 in muscle cells in culture: implications in the development of neuromuscular junctions. J Neurosci 1997;17:2947-2958.
59. Mirsky R, Jessen KR, Brennan A, Parkinson D, Dong Z, Meier C, et al. Schwann cells as regulators of nerve development. J Physiol (Paris) 2002;96:17-24.
60. Reddypalli S, Roll K, Lee HK, Lundell M, Barea-Rodriguez E, Wheeler EF. p75NTR-mediated signaling promotes the survival of myoblasts and influences muscle strength. J Cell Physiol 2005;204:819-829.
61. Gorospe JR, Tharp MD, Hinckley J, Kornegay JN, Hoffman EP. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J Neurol Sci 1994;122:44-56.
62. Lavasani M, Lu A, Peng H, Cummins J, Huard J. Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle. Hum Gene Ther 2006;17:180-192.
63. Capsoni S, Ruberti F, Di Daniel E, Cattaneo A. Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy. J Neurosci Res 2000;59:553-560.
64. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 2000;20:2589-2601.
65. Toti P, Villanova M, Vatti R, Schuerfeld K, Stumpo M, Barbagli L, et al. Nerve growth factor expression in human dystrophic muscles. Muscle Nerve 2003;27:370-373.
66. Stuerenburg HJ, Kunze K. Tissue nerve growth factor concentrations in neuromuscular diseases. Eur J Neurol 1998;5: 487-490.
67. Baron P, Scarpini E, Meola G, Santilli I, Conti G, Pleasure D, et al. Expression of the low-affinity NGF receptor during human muscle development, regeneration, and in tissue culture. Muscle Nerve 1994;17:276-284.
68. Kasemkijwattana C, Menetrey J, Bosch P, Somogyi G, Moreland MS, Fu FH, et al. Use of growth factors to improve muscle healing after strain injury. Clin Orthop 2000;370: 272-285.
69. Parolini D, Meregalli M, Belicchi M, Razini P, Lopa R, Carlo BD, et al. CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133(+) stem cells. Cell Mol Life Sci 2009;66:697-710.
70. Pitts EV, Potluri S, Hess DM, Balice-Gordon RJ. Neurotrophin and Trk-mediated signaling in the neuromuscular system. Int Anesthesiol Clin 2006;44:21-76.
71. Chevrel G, Hohlfeld R, Sendtner M. The role of neurotrophins in muscle under physiological and pathological conditions. Muscle Nerve. 2006;33:462-476.
72. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002;157:851-864.
73. Hsu YC, Lee DC, Chiu IM. Neural stem cells, neural progenitors, and neurotrophic factors. Cell Transplant 2007;16: 133-150.
74. Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K, Andersen JL, et al. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 2001;60: 302-312.
75. Munsat TL, Piper D, Cancilla P, Mednick J. Inflammatory myopathy with facioscapulohumeral distribution. Neurology 1972;22:335-347.
76. Figarella-Branger D, Pellissier JF, Serratrice G, Pouget J, Bianco N. Immunocytochemical study of the inflammatory forms of facioscapulohumeral myopathies and correlation with other types of myositis. Ann Pathol 1989;9:100-108.
77. Arahata K, Ishihara T, Fukunaga H, Orimo S, Lee JH, Goto K, et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 1995;2:S56-66.
78. Hengstman GJ, van Brenk L, Vree Egberts WT, van der Kooi EL, Borm GF, Padberg GW, et al. High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders. J Neurol 2005;252:534-537.
79. Lang CH, Frost RA, Vary TC. Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab 2007;293:E453-59.
80. Lang CH, Silvis C, Deshpande N, Nystrom G, Frost RA. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 2003;19:538-546.
81. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 2005;98:911-917.
82. Hussein MR, Hamed SA, Mostafa MG, Abu-Dief EE, Kamel NF, Kandil MR. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies. Int J Exp Pathol 2006;87:451-461.
83. Tidball JG, Wehling-Henricks M. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis. Curr Opin Rheumatol 2005;17:707-713.
84. Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, et al. A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 1997;48:46-49.
85. Fauchais AL, Lalloué F, Lise MC, Boumediene A, Preud'-homme JL, Vidal E, et al. Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol 2008;181:3027-3038.
86. Vega JA, Garcia-Suarez O, Hannestad J, Perez-Perez M, Germana A. Neurotrophins and the immune system. J Anat 2003;203:1-19.
87. Helliwell TR, Gunhan O, Edwards RH. Mast cells in neuromuscular diseases. J Neurol Sci 1990;98:267-276.
88. Barka T. Biologically active polypeptides in submandibular glands. J Histochem Cytochem 1980;28:836-859.
89. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 1994;91:3739-3743.
90. Horigome K, Bullock ED, Johnson EM. Effects of nerve growth factor on rat peritoneal mast cells. J Biol Chem 1994;269:2695-2702.
91. Tam SY, Tsai M, Yamaguchi M, Yano K, Butterfield JH, Galli SJ. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 1997;90:1807-1820.
92. Auernhammer CJ, Fottner C, Engelhardt D, Bidlingmaier M, Strasburger CJ, Weber MM. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells. Horm Res 2002;57:15-21.
93. Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F. Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand J Immunol 2003;57:493-497.